Diligence memo · auto-generated · as of July 2, 2026
Owp Pharmaceuticals, Inc.
Owp Pharmaceuticals, Inc. looks fair against its niche peers and is active on financing cadence.
Businessfiled
Owp Pharmaceuticals, Inc. operates in Pharmaceuticals, based in LISLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Owp Pharmaceuticals, Inc. has raised $5.1M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.7M on 2024-06-05.
Most recent recorded round closed around 2025-07-25.
Valuation (modeled)modeled
Provath models Owp Pharmaceuticals, Inc. at approximately $6.6M (range $1.8M–$13M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.07× the median modeled value of Seed Pharmaceuticals companies in 2025–2027 (19 peers) — value vs value, same stage and era. Within the normal band (107% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 14 months.
Last raise 11 mo ago; this sector typically re-raises about every 13 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 1.1× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 42% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 11% of those peers.
Closest niche peers: Kairos Pharma, LTD., Branch Therapeutics, Inc., ResBiotic Nutrition, Inc., Califia Pharma, Inc., BTB Therapeutics, Inc..
Peoplefiled
8 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.